Abilify MyCite® (aripiprazole tablets with sensor) – New drug approval
November 13, 2017 – The FDA announced the approval of Otsuka and Proteus’ Abilify MyCite (aripiprazole tablets with sensor), a drug-device combination product comprised of oral aripiprazole tablets embedded with an ingestible event marker (IEM) sensor.
Top